A recent study published in Ophthalmology Retina evaluated the relative risk associated with initiating GLP-1 agonist pharmacotherapy with these drug options on developing sight-threatening DR in routine clinical practice for patients with type 2 diabetes at moderate cardiovascular risk, which was defined as an annualized 1% to 5% predicted risk of experiencing a major adverse cardiovascular event
Cur-OST EQ Topline & Muscle 80% Organic pea protein L-glutamine L-arginine L-lysine L-creatine L-carnitine Flax seed Co-Enzyme Q10 Alpha Lipoic Acid Provides over 20 grams of highly-digestible plant based pea protein with supplemental amino acids at critical doses, along with Co-Enzyme Q10 and Lipoic Acid to support muscle development, strength, overall cellular function, digestive health, and cellular energy production
A Reality Thats Been Hard to See GLP-1based treatments can help many patients reach meaningful weight lossbut discontinuation suggests the lived patient experience may be complex
L- Energybody , Energybody Liquid 100 000 100 000 L-
Water, Glycerin, 1,2-Hexanediol, Glutathione, Glycyrrhiza Glabra (Licorice) Root Extract, Magnesium Ascorbyl Phosphate, Polyglutamic Acid, Ceramide NP, Astragalus Membranaceus Root Extract, Schisandra Chinensis Fruit Water, Butylene Glycol, Hydrogenated Lecithin, Allantoin, Tocopherol, Sodium Citrate, Sodium Phytate, Citric Acid, Polyglyceryl-10 Laurate, Ethylhexylglycerin
